Evaxion A/S Form 3 details insider holdings

Evaxion A/S filed an initial insider ownership report detailing equity interests related to its ordinary shares.

Rhea-AI Filing Summary

Evaxion A/S filed an initial insider ownership report detailing equity interests related to its ordinary shares. The filing lists warrants exercisable into 2,500,000 ordinary shares at an exercise price of $0.12 per share, expiring on December 31, 2031, with vesting at 1/36 per month over 36 months from the initial exercise date.

It also reports 2,286,150 ordinary shares held indirectly, noted as owned "By James Noble," who is identified in a footnote as the spouse of Dr. Tayton-Martin. The entry reflects holdings rather than new buy or sell transactions.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Evaxion A/S

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Warrants	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Warrants — 2,500,000 contracts (Direct); Ordinary Shares — 2,286,150 shares (Indirect, By James Noble)

Footnotes (2)

1. F1. Mr. Noble is Dr. Tayton-Martin's spouse.
2. F2. Vesting is 1/36 per month over 36 months from the initial exercise date indicated.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Evaxion A/S (EVAX) disclose in this Form 3 filing?

The Form 3 shows initial insider holdings in Evaxion A/S. It reports warrants for 2,500,000 ordinary shares at $0.12 per share and 2,286,150 ordinary shares held indirectly, establishing a baseline of reported ownership rather than recording new transactions.

How many Evaxion A/S ordinary shares are covered by the reported warrants?

The filing reports warrants linked to 2,500,000 ordinary shares. These warrants have an exercise price of $0.12 per share and expire on December 31, 2031, with vesting described as 1/36 each month over 36 months from the initial exercise date.

What indirect share ownership is reported for Evaxion A/S (EVAX)?

The Form 3 lists 2,286,150 ordinary shares as indirectly owned, described as held "By James Noble." A footnote explains that Mr. Noble is the spouse of Dr. Tayton-Martin, clarifying the relationship associated with this indirect ownership position.

Are there any buy or sell transactions in this Evaxion A/S Form 3?

No new buy or sell transactions are reported. The entries are classified as holdings, with transaction counts indicating unknown or neutral direction. Form 3 primarily establishes the insider’s existing ownership when they become subject to reporting, rather than documenting trades.

What are the key terms of the Evaxion A/S warrant position reported?

The warrants relate to 2,500,000 underlying ordinary shares, with an exercise price of $0.12 and an expiration date of December 31, 2031. Vesting occurs monthly at 1/36 over 36 months, starting from the stated initial exercise date in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 09:06 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Evaxion A/S

(Last) (First) (Middle)

DR. NEERGAARDS VEJ 5F

(Street)

HORSHOLM DK-2970

(City) (State) (Zip)

DENMARK

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Evaxion A/S [ EVAX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	2,286,150	I	By James Noble(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	01/11/2025(2)	12/31/2031	Ordinary Shares	2,500,000	$0.12	D

Explanation of Responses:

1. Mr. Noble is Dr. Tayton-Martin's spouse.

2. Vesting is 1/36 per month over 36 months from the initial exercise date indicated.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney. This initial holding statement has been made for Helen Katrina Tayton-Martin using the Issuer's CIK codes to satisfy Form 3 filing requirements. An amendment will be filed for Dr. Tayton-Martin upon receipt of her CIK filer codes from the SEC.

	/s/ Michael Baird, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)